Olesen, J., and Paulson, O.B.: The effect of intraarterial papaverine on the regional cerebral blood flow in patients with stroke and cerebral tumor. Stroke, 2: 148, 1971.
2.
Popendiker, K., Boksay, I., and Bollmann, V.: Zur Pharmakologic des neuen Peripheren Gefassdilators, 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin. Arzneim. Forsch., 21: 1160, 1971.
3.
Boksay, I., and Bollmann, V.: Der Einfluss von Methyl xanthinen auf β-adrenergic Mechanism. Arch. Pharmakol., 269: 441, 1971.
4.
Boksay, I., and Bollmann, V.: The effect of 3,7-dimethyl-1-(5-oxo-hexyl) xanthine on the β-adrenergic receptors and on the activity of isoprenaline. Arch. Int. Pharmacodyn., 194: 174, 1971.
5.
Hinze, H.J.: Zur Pharmakokinetik Von 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin (BL 191) am Menschen . Arzneim. Forsch., 22: 1492, 1972.
6.
Schafe, M. K., and Krause, W. (1969): quoted by Schafé (1973).
7.
Honegger, H.: In Vortrag BL 191: Symposium, Frankfurt, May 1971.
8.
Honegger, H. : Examination of the central circulation with the aid of ophthalmodynamographyFolia Angiologica, 21: 207, 1973.
9.
Hammer, O., and Neuner, A.: In Vortrag BL-191: Symposium, Frankfurt, May 1971.
10.
Varma, S.K., Natarajan, K., Mukherjee, A., and Singh Naunihal: A study of 25 stroke hemiplegics with sequential motor recovery. Proceedings of the First All India Workshop: conference on Stroke , November 1971. Tech. Rep. Series No. 23, pp. 87-92, 1973.
11.
Mansfeld, H.G. : Therapeutic experiences with a new xanthine derivative in peripheral and cerebral circulatory disturbances. DtschesMed. J., 23: 1, 1972.
12.
Schafé, M.K. : Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency. Münch. Med. Wochenschr. , 115: 40, 1745, 1973.
13.
Fellner, R. , and Simon A.: Clinical experience with a new vasotherapeutic agent in diseases of the fundus. Klin. Monatsbl. Augenheilk. , 162: 811, 1973.
14.
Jovanovie, U.J.: Polygraphic recordings following the parenteral application of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (BL 191 ). Arzneim. Forsch., 22: 994, 1972.
